Gland Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NETARSUDIL DIMESYLATE, with a corresponding US DMF Number 35954.
Remarkably, this DMF maintains an Active status since its submission on June 17, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2021, and payment made on August 16, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II